FOXM1 and breast carcinoma: Also, the AuNPs-AFPA group had reduced tumor growth rate compared with the AuNPs-AFPA-Dox group due to the lack of Dox, displaying the importance of combination therapy (co-delivery of Dox and FOXM1 Apt) in the treatment of breast cancer.